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Research Article
Chiral separation of rasagiline using
sulfobutylether--cyclodextrin: capillary
electrophoresis, NMR and molecular
modeling study
Pressure-assisted stereospecific capillary electrophoresis method was developed for the
determination of enantiomeric purity of the antiparkinsonian agent (R)-rasagiline. The
optimizedmethod, 50mMglycine-HCl buffer pH 2, supplied with 30mMsulfobutylether-
-cyclodextrin, at 35°C, applying 12 kV in reversed polarity, and –8 mbar pressure (vac-
uum), short-end injection with -25 mbar × 2 s, was successful for baseline separation of
rasagiline enantiomers (Rs = 3.5 ± 0.1) in a short analysis time. The method was validated
according to current guidelines and proved to be reliable, linear, precise and accurate
for determination of 0.15% S-enantiomer as chiral impurity in R-rasagiline sample, as
well as quantification of the eutomer. Method application was tested on a commercial
tablet formulation. Determination of spatial structure of diastereomeric associates was
based on 1H and 2D ROESY NMR, indicating that the aromatic moiety of the molecule
can enter the cyclodextrin cavity. NMR titration and molecular modeling revealed that
S-rasagiline formed a more stable inclusion complex with sulfobutylether--cyclodextrin,
than its antipode, which is in agreement with electrophoretic results.
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1 Introduction
Rasagiline (RAS, chemically known as (R)-N-(prop-2-ynyl)-
2,3-dihydro-1H-inden-1-amine, Fig. 1, used as amesylate salt)
is an irreversible inhibitor of monoamine oxidase B, used
for the treatment of the signs and symptoms of Parkinson’s
disease [1]. RAS has a single asymmetric carbon, resulting
in two optical isomers (R- and S-enantiomers). Only the R-
enantiomer is active, therefore, the drug is marketed as a
single enantiomeric agent, while the S-enantiomer could be
present as a chiral impurity [2]. Determination of chiral purity
of single enantiomeric agents is not only a necessity, but also
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a regulatory requirement. A literature survey revealed several
direct liquid chromatographic methods for the chiral separa-
tion of RAS enantiomers (Table 1) using polysaccharide [3,4],
crown ether [5] or protein-based chiral stationary phases [6].
To the best of our knowledge, CE was yet to be applied for
the chiral separation and subsequent enantiomeric quality
control of RAS.
Although liquid chromatography is the predominant
technique in chiral analysis, CE has also several advantages
in this field, due to its low solvent and analyte consumption,
high efficiency, and rapid analysis time. Moreover, the com-
bination of CE with other techniques, especially NMR spec-
troscopy and theoretical calculations can help gain insight
into the spatial structure and stoichiometry of diastereomeric
selector-selectand complexes and offer valuable information
upon the chiral discrimination process [7–11]. The aim of
the present study was to develop, optimize and validate a
fast and cost-effective CE method for the enantiomeric qual-
ity control of R-RAS using CDs as chiral selector. Moreover
1H and two-dimensional phase-sensitive rotating frame nu-
clear overhauser effect spectroscopy (2D ROESY) NMR as
well as molecular modeling study were also applied for the
characterization of non-covalent intermolecular interactions
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Figure 1. Constitutional formula and numbering of rasagilin.
of RAS-CD diastereomeric complexes and elucidation of the
possible enantiorecognation mechanism.
2. Materials and methods
2.1 Materials
R- and S-RAS, DMSO, D2O, DCl, glycine, sulfated--
CD with degree of substitution (DS)11 and gradient
grade methanol (MeOH) were purchased from Sigma-
Aldrich (Budapest, Hungary). -, -,  -CD, hydroxypropyl-
-CD (HP--CD) DS4.5, HP--CD DS4.5, HP- -CD
DS4.5,methyl--CDDS11,methyl--CDDS12,methyl-
 -CD DS13, heptakis(2,6-di-O-methyl)--CD content
95%, DS14, heptakis(2,3,6-tri-O-methyl)--CD, carboxy-
methylated--CD (CM--CD)DS3.5, CM--CDDS4, CM-
 -CD DS4 and sulfobutyl-ether--CD DS6.3 were prod-
ucts of Cyclolab (Budapest, Hungary). Tris, HCl and NaOH
were of analytical grade and purchased from commercial sup-
pliers. The deionized water was prepared by a Milli-Q Direct
8 Millipore system. Azilect R© 1 mg tablets (TEVA Pharma
GmbH) were obtained from a local pharmacy in Budapest,
Hungary.
2.2 CE measurements
CE experiments were performed on an Agilent 7100 CE
instrument (Agilent Technologies, Waldbronn, Germany),
equipped with a photodiode array detector and ChemSta-
tion software for data handling. An untreated fused-silica
capillary (50 µm id, 48.5 cm total and 40 cm effective length)
from Agilent was used for the separation. Conditioning of
new capillaries was conducted by flushing with 1 M NaOH
for 30 min followed by 0.1 M NaOH and water for 60 min
each. Prior to all runs the capillary was preconditioned by
flushing with 0.1 M NaOH (2 min), water (1 min), and BGE
(3 min). UV detection was performed at 200 nm. If not stated
otherwise, injections were carried out by applying a pressure
of 25 mbar for 3 s.
2.3 Preparation of BGE, stock, and sample solutions
For preliminary experiments 50 mM phosphate buffer ad-
justed to pH 6 was used; the BGE contained CDs in various
concentrations (3–30mM), the applied voltage was 20 kV and
the capillary was maintained at 25°C.
Application of the method was tested on a commercial
tablet formulation (Azilect R©). Twenty tablets were weighed
and afterwards ground and mixed in a mortar. Then 10 mL
MeOH was added to an accurately weighed portion of this
powder equivalent to 10 mg of RAS. The sample was soni-
cated for 30 min and then centrifuged for 10 min applying
4000 rpm (Sartorius 2–16P benchtop centrifuge, Goettin-
gen, Germany). The clear supernatant was filtered through
a 0.22 µm pore size syringe filter. An appropriate dilu-
tion was made with water to obtain the final concentrations
(100 µg/mL). For the determination of chiral impurity, water
was used as an extraction solvent, while the powder blendwas
weighed accurately as to obtain a theoretical concentration of
2666 µg/mL R-RAS.
R- and S-RAS stock solutions were prepared in methanol
at 1 mg/mL and were further diluted with water. The sam-
ple solution used during the preliminary CD screening ex-
periments contained approximately 150 µg/mL R-RAS and
30 µg/mL S-RAS. Other conditions including validation pro-
cess are given in Results and Discussion section.
2.4 NMR experiments
All NMR measurements were carried out on an Agilent
Varian Unity Inova DDR spectrometer (599.9 MHz for 1H)
with a 5 mm inverse-detection gradient probehead at 25°C.
Standard pulse sequences and processing routines available
Table 1. Direct liquid chromatographic methods for the chiral separation of RAS enantiomers
Stationary phase/Chiral selector Mobile phase Literature
Chiralcel OJ-H ((based on cellulose
tris(4-methylbenzoate))
hexane:isopropyl alcohol:ethanol:diethyl amine
(96:2:2:0.01))
[3]
Chiralpak AD-RH ((based on amylose
tris(3,5-dimethylphenylcarbamate))
20 mM potassium dihydrogen phosphate in
water-acetonitrile (65:35, v/v)
[4]
(+)-(18-crown-6)-2,3,11,12-tetracarboxylic acid ethanol/acetonitrile/acetic acid/triethylamine
(80:20:0.2:0.3, v/v/v/v)
[5]
Chiralpak AGP (based on 1-acid glycoprotein) ammonium acetate and isopropyl alcohol (90:10, v/v) [6]
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in VnmrJ 2.2C/Chempack 4 were used. The molecular ge-
ometry of the complex was investigated by two-dimensional
phase-sensitive rotating frame nuclear Overhauser effect
spectroscopy (2D ROESY). The structures of the inclusion
complexes were determined applying a spinlock of 3 kHz for
a mixing time of 300 ms.
The stability constants of RAS enantiomers were deter-
mined by 1H NMR titration in D2O. The pH was set at pH 2
using DCl. A stock solution containing 5 mM of both enan-
tiomers was prepared separately, while the SBE--CD stock
solution was 30 mM. 30 µL of RAS stock solution was mixed
with different volumes of SBE--CD stock solution and filled
to a total volume of 600 µL. The observed chemical shift (obs)
of a given nucleus can be expressed using the following for-
mula:
obs, = RAS
+
[RAS]T + [CD]T +
1
K
−
√(
[RAS]T + [CD]T +
1
K
)2
− 4[RAS]T[CD]T
2[RAS]T
(1)
where  = RAS−CD − RAS
The total concentration of RAS enantiomers ([RAS]T) was
constant during the titration.
Stability constants (K) of the inclusion complexes were
calculated by non-linear parameter fitting of Eq. (1) to the obs
versus [CD]T datasets using OriginPro 8 program based on
previous works [12–14].
2.5 Molecular modeling
In order to elucidate the atomic details of the enantiosepara-
tion, the interaction of RAS enantiomers and SBE--CD was
studied by using computational chemical tools. The model
structures were built by using GaussView 5.0. As the actual
configuration of SBE--CD is unknown (random substitution
of the OH groups), three different isomeric forms were cre-
ated to mimic the applied chiral selector based on the work of
Jain et al. [15]. In each case, seven SBE groups were added to
the-CD skeleton, as the degree of substitutionwas7 in the
experimental system (Fig. 2). Furthermore, the SBE groups
were properly distributed on the -CD skeleton to represent
the induced steric hindrance [15]. Energy minimization
of the SBE--CD isomers were performed by using the
optimized potentials for liquid simulations-AA forcefield in
combination with the Generalized Born implicit solvation
model. The resulted three optimized structures have been
used as hosts in docking simulations. The RAS enantiomers
were docked and their affinity towards the optimized
SBE--CD isomers were studied by applying a “blind dock-
ing” protocol [16] which was carried out by using AutoDock
Vina [17]. The size of the grid box was set to be 40× 40× 40 A˚
which ismuch bigger than the actual size of the isomers (host
molecules). The exhaustiveness and the maximum number
of binding modes was set to 8 and 9, respectively. The best
bindingmode from each simulation was selected and the cor-
responding structures and binding affinities were compared.
3 Results and discussion
3.1 CE method development
Sixteen different CDs were applied as potential chiral se-
lectors in the scouting phase. Through the application of a
high-number of different CD derivatives, the effect of differ-
ences in the cavity size, nature of the substituents and charge
upon enantiorecognition was also tracked. During the initial
scouting phase, the chiral recognition ability of each selector
was checked at five concentration levels (3-30 mM) at pH 6
in a 50 mM phosphate buffer. The capillary temperature was
kept at 25°C and 20 kV voltage was applied. From the six-
teen studied CDs eight CD derivatives (CM--CD, CM--CD,
CM- -CD, HP--CD, methyl--CD, DIMEB, sulfated--CD
and SBE--CD) showed chiral interactions with the analyte,
with SBE--CD at 30 mM delivering the most promising re-
sults. Higher concentration of chiral selector resulted in bet-
ter enantioseparation, however concentration above 30 mM
could not be applied because of the high current generated.
In all cases the migration order was not the ideal one,
because the eutomer R-RAS was migrating first, followed by
the S-enantiomer. For further method development our aim
Figure 2. 2D structures of sulfobutylether--cyclodextrin isomers, where R = sulfobutylether group.
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was to reverse the enantiomer migration order (EMO), while
still maintaining baseline separation.
One of the main advantages of CE enantioseparation is
the ease of reversing EMO, when compared to chromato-
graphic methods. In our recent study, we have successfully
reversed the enantiomer migration order for praziquantel, by
polarity switching and EOF reduction at strongly acidic BGE
[18]. The same simple approach was employed in this study
also, together with reduction of the effective length of the sep-
aration capillary to 8.5 cm, by employing short-end injection
technique. Using 50 mM phosphate buffer pH 2.0, supple-
mented with 30mMSBE--CD at 25 °C, hydrodynamic injec-
tion at the near-detector-end of the capillary (-25mbar x 3 sec),
and applying 15 kV (reversed polarity), the EMOwas reversed
and the ideal situation,when thedistomer,S-RASwas thefirst
migrating enantiomer, followed by the R-RAS was obtained.
Further, method optimization was undertaken to im-
prove peak shape and further reduce analysis time. Higher
concentrations than 30 mM of the ionized SBE--CD and/or
50 mM phosphate buffer could not be utilized, because of
the high currents generated. In the following, several vari-
ations of voltage and temperature were employed to further
optimize themethod, but still maintain currents below100-
110 µA. Best results were obtained at a higher capillary tem-
perature (35 °C), which implied lowering the voltage to 12 kV.
However, using these conditions, the total analysis time was
still longer than 17 minutes and peak shapes and efficiencies
were still not ideal. In order to overcome these shortcomings,
vacuum was applied to the outlet vial. This pressure-assisted
approach lead to better peak shapes, overall higher efficien-
cies and reduced analysis time, but also decreased Rs values
Figure 3. Effect of applied pressure on the enantioseparation
of.RAS enantiomers. (A) 0 mbar; (B) -5 mbar*; (C) -7 mbar*; (D)
-8 mbar*; (E) -10 mbar*; (F) -15 mbar*. Other experimental con-
ditions: BGE: 50 mM phosphate buffer pH 2.0, 30 mM SBE--CD;
temperature: 35°C; 25 mbar x 2 sec hydrodynamic injection at the
short-end of the capillary; applied voltage: 12 kV (reversed polar-
ity, cathode at inlet). *Negative pressure indicates that vacuum
was applied at the end of the capillary, in order to pull the sample
plug through the detector.
(Fig. 3). A good compromise between reduced analysis time,
but still sufficient enantioselectivity was obtained by applying
-8 mbar pressure. As a last step, the influence of changing
the BGE buffer system was investigated. Phosphate buffer,
Tris-HCl and glycine-HCl all in a 50 mM concentration at
pH 2.0 were employed as BGE constituents. No difference in
migration times were recorded, however peak shapes were
better using glycine-HCl buffer. Using these optimized con-
ditions (50mMglycine-HCl buffer pH 2.0, 30mMSBE--CD
(DS 6.3), capillary temperature: 35°C, applied voltage 12 kV
(reversed polarity) and – 8mbar pressure, short-end injection
with -25 mbar × 2 sec) high resolution (Rs = 3.5 ± 0.1) was
achieved within 8 min. Therefore, further method optimiza-
tion was not applied.
3.2 Method validation
Our developedmethod was validated for the determination of
S-RAS as a potential optical impurity inR-RAS sample and for
quantification of R-RAS following the International Council
on Harmonization (ICH) guidelines in terms of sensitivity
(LOD, LOQ), linearity, precision and accuracy.
3.2.1 Method validation for the determination of
S-RAS as a potential optical impurity
Method sensitivity was evaluated for the determination of
S-RAS, by sequentially diluting sample solutions. The LOD
of S-RAS was determined as the concentration yielding a
signal three times the baseline noise while LOQ was deter-
mined at 10:1 signal to noise ratio in the presence of R-
RAS solution. The LOQ was determined at 4 µg/mL (cor-
responding 0.15% impurity in 2666 µg/mL R-RAS sample),
while LOD of S-RAS was 2 µg/mL (corresponding 0.075%
impurity in 2666 µg/mL R-RAS sample). Calibration curve
was constructed at six different concentration levels be-
tween 4 and 48 µg/mL corresponding to 0.15%-1.8% enan-
tiomeric impurity in 2666 µg/mL R-RAS solution. Regres-
sion analysis shows a linear relationship in the above men-
tioned concentration ranges with the following equations: y
= 1.1809x + 0.2919 (r2 = 0.9994). Accuracy (calculated as re-
covery%) and precision (repeatability based on RSD% of the
migration time and peak area) were analyzed by performing
intra-and interday evaluation of three concentration levels 4,
16 and 40 µg/mL for S-RAS in the presence of R-RAS. In the
intraday repeatability study, the RSD% ofmigration time was
lower than 0.5%, In the interday repeatability (measured in
two consecutive days) the RSD% ofmigration time was lower
than 1.5%. The accuracy data and RSD% of peak areas are
summarized in Table 2.
3.2.2 Method validation for quantification of R-RAS
Our method was also validated and applied for quantifica-
tion of R-RAS. In this case calibration curve was constructed
C© 2019 The Authors. Electrophoresis published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. www.electrophoresis-journal.com
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Table 2. The accuracy data and RSD% of peak areas of S-RAS as a potential optical impurity in presence of R-RAS
S-RAS concentration in 2666 µg/mL R-RAS Precision (RSD%) Accuracy (%)
Intraday Interday Intraday Interday
4 µg/mL (0.15%) 3.1 4.5 96.1 96.3
16 µg/mL (0.6%) 1.2 1.6 101.5 99.7
40 µg/mL (1.5%) 4.1 2.3 99.8 102.3
Table 3. The accuracy data and RSD% of peak areas of R-RAS
R-RAS concentration Precision (RSD%) Accuracy (%)
Intraday Interday Intraday Interday
80 µg/mL 3.5 3.9 99.8 97.7
100 µg/mL 0.5 1.1 100.9 101.1
120 µg/mL 1.3 2.3 97.8 99.9
between 80 and 120 µg/mL of R-RAS. The results indicate
a linear relationship with the following regression equation:
y = 1.472x + 0.0964 (r2 = 0.9996). Like the validation of
determination of potential chiral impurity, the accuracy and
precision of the method was tested. Quality control samples
were prepared at concentration of 80, 100 and 120 µg/mL for
R-RAS. The RSD% of migration time was lower than 0.2%
and 0.9% in the case of intra- and interday repeatability, re-
spectively. Further results regarding accuracy and precision
are summarized in Table 3.
3.3 Application of the method
Our optimized and validatedmethodwas applied for the assay
and enantiomeric quality control ofR-RAS in Azilect R© tablets
(containing 1 mg R-RAS in mesylate salt form). In the ana-
lyzed samples, no chiral impurity could be detected, however
after spiking the sample with the distomer to achieve 0.15%
chiral impurity, S-RAS could be determined (Fig. 4). More-
over, during the assay of R-RAS, a good agreement between
the value claimed by the manufacturer and that determined
by our method (1.03 ± 0.03 mg/tablet) was obtained. The
real sample analysis further underlines the applicability of
our method.
3.4 NMR and molecular modeling for
characterization of enantioselective
complexation
At first in the 1H NMR measurements, spectrums were
recorded using a solution containing 3 mM sample with
7:1 R:S enantiomeric ratio, with increasing concentrations
of SBE--CD (0, 5, 15, 20,30 mM) to check a possible
enantioselective differences. In the 1H NMR spectra the
complexation-induced chemical shift is clearly indicative
of selector-selectand complexation, moreover some minor
Figure 4. Electropherogram of a solution of Azilect R© tablets con-
taining 2666 µg/mL R-RAS spiked with 0.15% S-RAS chiral impu-
rity. Conditions: BGE: 50 mM glycine-HCl buffer pH 2.0, 30 mM
SBE--CD; temperature: 35°C; 25 mbar x 2 sec hydrodynamic in-
jection at the short-end of the capillary; applied voltage: 12 kV
(reversed polarity, cathode at inlet).
signal splitting was also observed due to nonequivalence
of complexation induced chemical shifts of enantiomers in
the aromatic region applying higher selector concentration
(15mM) (Fig. 5A). The chemical shift differences for S-RAS
were higher than R-RAS, indicating that the S-enantiomer
formed more stable complex with SBE--CD. To determine
the exact stability constant 1HNMR titration was applied. The
stability constant for R-RAS and S-RAS SBE--CD were 2.18
± 0.02 and 2.35 ± 0.01, respectively. These data are in good
accordance with the observed EMO in CE measurements.
2D ROESY NMRmeasurement was applied for determi-
nation of spatial structure of the RAS enantiomer- SBE--CD
complexes. Crosspeaks between RAS aromatic protons and
inner H3 and H5 protons of the CD clearly show that the
phenyl ring can enter the CD cavity. Based on ROESY exper-
iments enantiomer specific complexation was not observed
(Fig. 5B).
Docking simulationwas used to aid in the understanding
of the mechanism of the separation. The tridimensional
structures of the diastereomeric complexes between RAS
enantiomers and three different SBE--CD isomers are
presented in Fig. 5, together with the calculated relative
binding affinities of complex formation. Results of the
C© 2019 The Authors. Electrophoresis published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. www.electrophoresis-journal.com
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Figure 5. (A) The aromatic
part of 1H NMR spectrum
of R-enantiomer-enriched RAS
(3 mM sample with 7:1 R:S
enantiomeric ratio) without
SBE--CD (down) and with
30 mM SBE--CD (top). (B) 2D
ROESY spectrum of a sample
containing 3 mM SBE--CD,
2.5 mM R-RAS and 1.5 mM
S-RAS, showing ROE cross-
peaks between the aromatic
protons (H-6, H-7 and H-8) of
RAS with inner H3 and H5 pro-
tons of SBE--CD.
Figure 6. 3D structures of
the diastereomeric complexes
between RAS enantiomers
and SBE--CD isomers to-
getherwith the calculated rela-
tive binding affinities (S-REA,
kcal/mol). S-REA = EA(S) –
EA(R), where EA(S) and EA(R)
are the binding affinity of the
complex formed with S-RAS
and R-RAS enantiomers, re-
sepectively. S-RAS and R-RAS
indicated with light green and
orange color.
molecular modeling study are in line with experimental
observations: a more stable complex was formed between
the chiral selector, SBE--CD and S-RAS, causing the later to
reach the detector faster in the reversed polarity setup, than
R-RAS. The study also confirmed the preferential inclusion
of the aromatic part of the analyte in the cavity of the CD,
the N-propargyl side-chain of RAS points outside of the
cavity. In the case of R-RAS this positively charged side-chain
points towards the apolar side-chain of the sulfobutyl
group, whereas for S-RAS, the N-propargyl group points
away. Energetically, the latter case is more favorable. We
hypothesize that the electrostatic interactions between the
negatively charged CD and the positively charged analyte are
primary responsible for anchoring the enantiomers (leading
interactions) and bringing the asymmetric moieties of the se-
lector and selectand in close proximity [19,20]. Enantiomeric
discrimination most probably occurs afterwards, when the
differences in secondary interactions, give rise to a more
stable complex for S-RAS. Based on molecular modeling
study it is evident, that S-RAS established more secondary
C© 2019 The Authors. Electrophoresis published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. www.electrophoresis-journal.com
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interactions (H-bonding, -NH—O-; and -interactions)
with the SBE--CD isomers in each case, than its R-RAS
counterpart (Fig. 6).
4 Concluding remarks
A novel, rapid enantioselective pressure-assisted CE method
using SBE--CD as chiral selector has been established for
the determination of enantiomeric purity of RAS for the first
time. Applying the optimized conditions 50 mM glycine-HCl
buffer pH 2.0, supplied with 30 mM SBE--cyclodextrin,
at 35°C, applying 12 kV in reversed polarity, and –8 mbar
pressure (vacuum), short-end injection with -25 mbar × 2 s,
baseline separation of RAS enantiomers was achieved within
8 min. Our optimized and validated method can be success-
fully applied for the quality control ofR-RAS.UsingNMRand
molecular modeling the SBE--CD RAS inclusion complex-
ation was characterized. Different binding affinities of the
individual enantiomers towards SBE--CD were identified
with both NMR and molecular modeling, in favor of the S-
enantiomer, which are in accordance with the observed EMO.
We assume that the secondary interactions with smaller en-
ergies could play a bigger role in the enantiomer recognition
mechanism. In our work we proved that by combined use of
CE, nuclear magnetic resonance spectroscopy and molecular
modeling calculations can help to gain deeper understanding
of the chiral recognition mechanism of CD chiral selectors.
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